Department of General Surgery and Surgical Specialties "Paride Stefanini", Sapienza University of Rome, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161, Rome, Italy.
Department of General Surgery, Università Politecnica delle Marche, Piazza Roma 22, 60121, Ancona, Italy.
World J Surg. 2020 Mar;44(3):810-818. doi: 10.1007/s00268-019-05287-2.
The aim of this case-control study is to compare the surgical outcomes of laparoscopic adrenalectomy (LA) for lesions measuring ≥6 cm versus ≤5.9 cm in diameter.
Eighty-one patients with adrenal gland lesions ≥6 cm in diameter (intervention group) were identified. Patients were matched to 81 patients with adrenal gland ≤5.9 cm in diameter (control group) based on disease (Conn-Cushing syndrome, pheochromocytoma, primary or secondary adrenal cancer or other disease), lesion side (right, left), surgical technique (anterior transperitoneal approach for right and left LA or anterior transperitoneal submesocolic for left LA) and body mass index class (18-24.9, 25-29.9, 30-34.9, 35-39.9, ≥40 kg/m). Surgical outcomes were compared between the intervention and control groups.
Mean operative time was statistically significantly longer in the interventional arm (101.4 ± 52.4 vs. and 85 ± 31.6 min, p = 0.0174). Eight conversions were observed in the intervention group (9.8%) compared to four in the control group (4.9%) (p = 0.3690). Five (6.1%) and three (3.7%) postoperative complications were observed in the intervention and control groups, respectively (p = 0.7196). Mean postoperative hospital stay was 4.6 ± 2.4 and 4.1 ± 2.3 days in the intervention and control groups, respectively (p = 0.1957).
Operative time was statistically significantly longer in adrenal gland lesions ≥6 cm in diameter (vs. ≤5.9 cm). Conversion and complication rates were also higher, but the difference was not statistically significant. Based on the present data, adrenal gland lesions ≥6 cm in diameter are not an absolute contraindication to the laparoscopic approach.
本病例对照研究旨在比较直径≥6cm 与≤5.9cm 的腹腔镜肾上腺切除术(LA)的手术结果。
共确定 81 例肾上腺直径≥6cm 的病变患者(干预组)。根据疾病(Conn-Cushing 综合征、嗜铬细胞瘤、原发性或继发性肾上腺癌或其他疾病)、病变侧(右侧、左侧)、手术技术(右侧和左侧 LA 的前经腹腔途径或左侧 LA 的前经腹腔肠系膜下途径)和体重指数分类(18-24.9、25-29.9、30-34.9、35-39.9、≥40kg/m²),将患者与 81 例肾上腺直径≤5.9cm 的病变患者(对照组)进行匹配。比较干预组和对照组之间的手术结果。
干预组的平均手术时间明显长于对照组(101.4±52.4 分钟比 85±31.6 分钟,p=0.0174)。干预组发生 8 例中转开腹(9.8%),对照组为 4 例(4.9%)(p=0.3690)。干预组和对照组分别有 5 例(6.1%)和 3 例(3.7%)发生术后并发症(p=0.7196)。干预组和对照组的平均术后住院时间分别为 4.6±2.4 天和 4.1±2.3 天(p=0.1957)。
肾上腺直径≥6cm 的病变患者的手术时间明显长于直径≤5.9cm 的病变患者。中转开腹率和并发症发生率也较高,但差异无统计学意义。基于目前的数据,直径≥6cm 的肾上腺病变并不是腹腔镜手术的绝对禁忌证。